Education
About Us
Working with TipRanks
Follow Us
Virbac SA (GB:0NM7)
:0NM7
0NM7 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€255.00 - €399.00
Previous CloseN/A
Volume98.00
Average Volume (3M)2.13K
Market Cap
€2.85B
Enterprise Value€1.94B
Total Cash (Recent Filing)€149.63M
Total Debt (Recent Filing)€307.01M
Price to Earnings (P/E)20.5
Beta0.59
Next Earnings
Sep 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 24, 2025Dividend Yield0.43%
Share Statistics
EPS (TTM)6.04
Shares Outstanding8,390,660
10 Day Avg. Volume546
30 Day Avg. Volume2,135
Financial Highlights & Ratios
PEG Ratio2.03
Price to Book (P/B)2.29
Price to Sales (P/S)0.00
P/FCF Ratio42.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€390.00Price Target Upside14.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Virbac SA News
Bulls Say, Bears Say
Bulls Say
Regional GrowthEurope and Latin America are showing strong growth rates of approximately +8%, setting a positive outlook for the year.
Sales PerformanceVirbac's 1Q25 sales figures reached €375m, aligning perfectly with expectations and reflecting organic growth of +4.9%.
Bears Say
Earnings GrowthA slowdown in earnings growth is expected to continue due to an unfavorable base effect.
Regional ChallengesAustralia's market conditions are unfavorable, leading to a significant downturn of -15% in the region.
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
6.39%
Mutual Funds
― Other Institutional Investors
90.60% Public Companies and
Individual Investors
0NM7 FAQ
What was Virbac SA’s price range in the past 12 months?
Virbac SA lowest share price was €255.00 and its highest was €399.00 in the past 12 months.
What is Virbac SA’s market cap?
Virbac SA’s market cap is €2.85B.
When is Virbac SA’s upcoming earnings report date?
Virbac SA’s upcoming earnings report date is Sep 12, 2025 which is in 56 days.
How were Virbac SA’s earnings last quarter?
Virbac SA released its earnings results on Mar 13, 2025. The company reported €6.045 earnings per share for the quarter, beating the consensus estimate of N/A by €6.045.
Is Virbac SA overvalued?
According to Wall Street analysts Virbac SA’s price is currently Undervalued.
Does Virbac SA pay dividends?
Virbac SA pays a Annually dividend of €1.45 which represents an annual dividend yield of 0.43%. See more information on Virbac SA dividends here
What is Virbac SA’s EPS estimate?
Virbac SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Virbac SA have?
Virbac SA has 8,390,660 shares outstanding.
What happened to Virbac SA’s price movement after its last earnings report?
Virbac SA reported an EPS of €6.045 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.974%.
Which hedge fund is a major shareholder of Virbac SA?
Currently, no hedge funds are holding shares in GB:0NM7
Company Description
Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.